1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Zecotek Photonics Inc.

Zecotek Photonics Inc.

ZMSPF
Zecotek Photonics Inc.US flagOther OTC
0.00
USD
- -
- -
1,649.00Market Cap
Zecotek Photonics Inc.
ZMSPF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
TTM
FRC
- -
- -
- -
- -
0.01
0.01
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
Revenue per Share
-0.01
-0.13
-0.2
-0.22
-0.19
-0.1
-0.16
-0.08
-0.08
-0.09
-0.09
-0.07
-0.04
-0.02
-0.03
-0.03
-0.01
Basic EPS, GAAP
-0.01
-0.13
-0.07
-0.19
-0.18
-0.05
-0.09
-0.07
-0.05
-0.04
-0.07
-0.04
-0.03
-0.03
-0.04
-0.05
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.06
-0.76
-0.49
-0.59
-0.69
-0.76
-0.84
-0.79
-0.21
-0.81
-0.73
-0.7
-0.18
-0.16
-0.13
-0.15
-0.15
Book Value per Share
- -
0.13
0.14
0.07
0.06
-0.02
-0.07
0.01
-0.05
-0.04
-0.03
-0.05
-0.06
-0.05
- -
-0.03
-0.03
Tangible Book Value per Share
6
10
28
38
44
46
51
61
68
74
94
108
117
131
153
165
165
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
-32,666.69
-6,235.19
-11,029.52
-2,779.47
-1,288.45
-10,768.21
-8,353.11
-14,129.16
-17,746.73
-9,855.11
-1,578.55
-355.39
-696.74
-3,288.87
-4,222.11
-1,588.89
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-6
-8
-8
-5
-8
-5
-5
-7
-8
-7
-5
-3
-5
-5
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-32,666.69
-12,988.17
-11,131.39
-2,765.49
-1,316.93
-11,921.05
-8,594.55
-14,129.16
-17,834.6
-9,768.43
-1,586.07
-352.41
-647.58
-2,444.76
-4,063.02
-782.25
Profit Margin (%)
- -
1
4
1
1
-2
-4
- -
-3
-3
-3
-6
-8
-6
-1
-6
-5
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
3
4
3
3
-1
-4
1
-3
-3
-3
-6
-7
-6
- -
-4
-5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
9.09
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'20
Jan'20
Apr'20
ST Debt
5
- -
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
165
165
165
Market Capitalization
2
2
- -

Working Capital

FRC

•

in mil. unless spec.
Oct'20
Jan'20
Apr'20
Total Current Assets
1
12
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
18
8
Payables & Accruals
2
1
1
ST Debt
5
- -
4
Deferred Revenue
1
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-118.26%
-201.7%
-1,017.51%
Free Cash Flow
21.7%
9.62%
23.02%
Net Income, GAAP
6.98%
-5.48%
-6.58%
Sales/Revenue/Turnover
47.68%
96.45%
-43.79%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
-0.01
-0.01
- -
-0.03
2019
-0.01
-0.01
-0.01
- -
-0.03
2020
-0.01
- -
0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
Similar Companies
Business Alignment Public Company Limited (BIZ.BK)
Neola Medical AB (publ) (NEOLA.ST)
Vieworks Co., Ltd. (100120.KQ)
Calmare Therapeutics Incorporated (CTTC)
Applied BioCode Corporation (6598.TW)
Family Office of America Inc. (FOFA)
Business
Zecotek Photonics Inc. (ZMSPF) develops and commercializes advanced photonics technologies and products for applications in medical imaging, 3D display, laser systems, and telecommunications. The company offers core products including solid-state 3D displays utilizing parallax barrier technology; single-crystal scintillator wafers and arrays for Positron Emission Tomography (PET) scanners; high-performance pulsed DPSS (diode-pumped solid-state) lasers under the Z-Laser brand; and fiber lasers and amplifiers for industrial and telecom uses. Zecotek also provides customized photonics modules and OEM components, such as lanthanum bromide scintillators branded as LFS, serving healthcare diagnostics, entertainment, defense, and fiber-optic markets. Founded in 2004 and headquartered in Vancouver, Canada, Zecotek operates globally with research and manufacturing facilities in Singapore, Malaysia, and Russia, targeting enterprise customers including medical device manufacturers, display OEMs, and laser system integrators across North America, Europe, and Asia. The company focuses on proprietary technologies like its patented Hybrid Glass Waveguide for AR/VR displays and scintillator crystal growth processes that enhance imaging resolution and speed. Subsidiaries include Zecotek Display Systems Pte. Ltd. and Zecotek Laser Systems Pte. Ltd., supporting its vertically integrated operations from R&D to production. In recent developments, Zecotek announced a strategic rebranding and operational restructuring in late 2024 to streamline its photonics portfolio amid market expansion in medical imaging; this included a new partnership with a leading PET scanner producer for LFS scintillator supply and a funding round to accelerate fiber laser production scaling. The company launched an upgraded Z-Laser series in early 2025, featuring higher pulse energy for defense applications, and expanded into hybrid waveguide displays through a licensing alliance with an Asian electronics firm. These changes position Zecotek for growth in high-resolution imaging and next-generation laser markets, with no reported parent company affiliation.